These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 36495700)

  • 1. Discrete-event simulation study of a COVID-19 mass vaccination centre.
    Sala F; D'Urso G; Giardini C
    Int J Med Inform; 2023 Feb; 170():104940. PubMed ID: 36495700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. If the public can vaccinate, why not students? Review of a student nurse placement in a mass vaccination centre.
    Thornton M; Jones L; Jones R; Lusardi G
    Br J Nurs; 2022 Apr; 31(7):386-392. PubMed ID: 35404653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence Model of Drive-Through Vaccination Simulation.
    Asgary A; Valtchev SZ; Chen M; Najafabadi MM; Wu J
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33396526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
    Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
    Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination site.
    Signorelli C; Odone A; Gianfredi V; Capraro M; Kacerik E; Chiecca G; Scardoni A; Minerva M; Mantecca R; Musarò P; Brazzoli P; Basteri P; Bertini B; Esposti F; Ferri C; Alberti VA; Gastaldi G
    Ann Ig; 2021; 33(5):499-512. PubMed ID: 34113956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass production methods for mass vaccination: improving flow and operational performance in a COVID-19 mass vaccination centre using Lean.
    Smith IM; Smith DTL
    BMJ Open Qual; 2021 Sep; 10(3):. PubMed ID: 34518300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
    Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.
    Wang T; Li C; Li H; Li Z
    BMJ Open; 2022 Jul; 12(7):e057281. PubMed ID: 35831042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned.
    Palmer K; Nemer L; Datta SS; Menne BM
    Front Public Health; 2022; 10():959227. PubMed ID: 36211689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 Massive Vaccination Center Layouts.
    Brambilla A; Mangili S; Macchi M; Trucco P; Perego A; Capolongo S
    Acta Biomed; 2021 Oct; 92(S6):e2021446. PubMed ID: 34739468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 mass vaccination campaign for healthcare workers in a low-resource setting: A clinician-driven initiative.
    Reddy DL; Dangor Z; Lala N; Johnstone J; Maswabi L; Tsitsi JML
    S Afr Med J; 2021 May; 111(7):610-614. PubMed ID: 34382541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drive-Through Mass Vaccination Center Operations in a Rural, Medically Underserved Area Using Military Civilian Partnership During the COVID-19 Pandemic.
    Rowh M; Rowh A; Lambert S; Nickerson H; Webb C
    Disaster Med Public Health Prep; 2023 Mar; 17():e354. PubMed ID: 36924184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
    PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic.
    Asgary A; Najafabadi MM; Karsseboom R; Wu J
    Healthcare (Basel); 2020 Nov; 8(4):. PubMed ID: 33182336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 mass vaccination - an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns.
    Roseline M; Luc C; Julien L; Olivier E; Etienne B; Pierrick B
    Emerg Microbes Infect; 2022 Dec; 11(1):804-806. PubMed ID: 35230221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies.
    Janssen C; Mosnier A; Gavazzi G; Combadière B; Crépey P; Gaillat J; Launay O; Botelho-Nevers E
    Hum Vaccin Immunother; 2022 Nov; 18(6):2131166. PubMed ID: 36256633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing an efficient scheduling template of a chemotherapy treatment unit: A case study.
    Ahmed Z; Elmekkawy T; Bates S
    Australas Med J; 2011; 4(10):575-88. PubMed ID: 23386870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting willingness to be vaccinated for Covid-19: Evidence from New Zealand.
    Kaine G; Wright V; Greenhalgh S
    PLoS One; 2022; 17(4):e0266485. PubMed ID: 35390053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.